D. Alison

A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.

Z. Siddik, D. Newell, T. Mcelwain, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.

A. Calvert, K. Harrap, A. Jackman, 1986, Cancer research.